Pfizer Under Investigation By New York AG Spitzer
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is under investigation by the New York State Attorney General for possible off-label promotion
You may also be interested in...
Brand Rx Prices Increased Half A Percent On Average From July To September
AARP/University of Minnesota pricing survey finds the average rate of increase for 197 drugs slowed in comparison to the 1% rise in prices between April and June and the 3.5% increase observed from January to March.
Aggressive Patents Should Have Senior Management Support, Pfizer Attorney Says
Management should "buy-in" before controversial patents that could delay generic entry are listed, Pfizer Senior Patent Counsel Pokras says. Pokras suggests that some people, including state prosecutors, would not see the "connection" between a patent on a metered dose device and the drug product.
Aggressive Patents Should Have Senior Management Support, Pfizer Attorney Says
Management should "buy-in" before controversial patents that could delay generic entry are listed, Pfizer Senior Patent Counsel Pokras says. Pokras suggests that some people, including state prosecutors, would not see the "connection" between a patent on a metered dose device and the drug product.